Glucotrack, Inc. Files Q1 2025 10-Q Report

Ticker: GCTK · Form: 10-Q · Filed: May 14, 2025 · CIK: 1506983

Glucotrack, INC. 10-Q Filing Summary
FieldDetail
CompanyGlucotrack, INC. (GCTK)
Form Type10-Q
Filed DateMay 14, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, quarterly-report, medical-devices

TL;DR

Glucotrack filed its Q1 2025 10-Q. Check financials.

AI Summary

Glucotrack, Inc. filed its quarterly report for the period ending March 31, 2025. The company, previously known as Integrity Applications, Inc., is based in Rutherford, NJ, and operates in the surgical and medical instruments sector. The filing covers the first quarter of 2025, with financial data from the end of 2023 and 2024 also included for comparison.

Why It Matters

This filing provides investors with an update on Glucotrack, Inc.'s financial performance and operational status for the first quarter of 2025.

Risk Assessment

Risk Level: low — This is a standard quarterly filing with no immediate red flags or significant new disclosures.

Key Numbers

Key Players & Entities

FAQ

What is the primary business of Glucotrack, Inc.?

Glucotrack, Inc. operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry, SIC code 3841.

When was the company formerly known as Integrity Applications, Inc.?

The company changed its name from Integrity Applications, Inc. on March 28, 2022.

What is the fiscal year end for Glucotrack, Inc.?

The fiscal year end for Glucotrack, Inc. is December 31.

What is the SEC file number for Glucotrack, Inc.?

The SEC file number for Glucotrack, Inc. is 001-41141.

Where is Glucotrack, Inc. located?

Glucotrack, Inc.'s business and mailing address is 301 RT 17 NORTH, SUITE 800, RUTHERFORD, NJ 07070.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding Glucotrack, Inc. (GCTK).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing